|Day Low/High||1.80 / 1.92|
|52 Wk Low/High||1.09 / 4.30|
Intuitive Surgical may be a battleground stock, but it has the fundamentals to win the war, says Tao Levy, Managing Director at Wedbush Securities.
Insiders at these companies have been scooping up shares of their own stock lately.
Cardica's CEO Discusses F4Q12 Results - Earnings Call Transcript
Cardica have been on a roll of late and the company is apparently striking while the iron is hot with plans to sell $40 million worth of stock and warrants.
Cardica continued to rally on Monday, rising for a second straight session following a bullish analyst initiation based on optimism about its Microcutter product.
All it takes is one big drug approval, a buyout from big pharma or a plump contract from a major provider to send shares of penny stocks like these soaring.
Cardica shares fall in premarket trading following lower-than-expected 4th-quarter revenue
Cardica 4th qtr sales miss estimates, and company says it can't give fiscal 2010 outlook
Cardica shares surged after it got approval for its PAS-Port system for use in cardiac bypass surgery.
Regulators warn of two deaths possibly related to its diabetes drug.
A look at five stocks experiencing phenomenal growth and the concept of diversification.
Stocks are at a standstill, but crude and copper surge as the dollar tumbles. Insights from Mark Dow, Dan Fitzpatrick and "Papa Bear" Nouriel Roubini.
The odds are equally weighted between a bounce and a selloff, so let other traders throw money at the market.
Expect 2007 to bring more of the discounted offerings we saw last year in this sector.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.